David Burns’ practice focuses on antitrust and competition law, representing businesses in merger reviews and government investigations before the Department of Justice and Federal Trade Commission, and in antitrust litigation in federal court. David also regularly provides sophisticated counseling for avoidance of antitrust liability on topics such as pharmaceutical patent litigation settlements, IP licensing, joint ventures and the HSR merger review process.

Download full bio 


  • Otsuka Enters Worldwide Collaboration Agreement With Sunovion and Sumitomo Dainippon Pharma 

  • Intersect ENT Agrees to Sell to Medtronic for More Than $1 Billion 

  • IRL Reaches Unicorn Status With Series C Round 

  • Snapdocs Valuation Climbs to Over $1.5 Billion With Series D Round 

  • The Honest Company – $475 Million IPO 

  • View all


  • George Washington University Law School
    JD, with honors, 2011

  • Middlebury College
    BA , 2007

Admissions & Credentials

District of Columbia



  • American Bar Association

Rankings & Accolades

    Super Lawyers Rising Stars: Antitrust (2018-2020)

    Best Lawyers: Antitrust Law, Ones to Watch

    Legal 500: Merger Control (2021)